Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Liver Cancer 2016 NIGMS 1P20GM113126-01 5964 Quantifying Biochemical Communication in Hepatocellular Carcinoma STAINS, CLIFF UNIVERSITY OF NEBRASKA LINCOLN NE $180,126
Liver Cancer 2016 NIGMS 1P20GM113226-01 6174 High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis DENG, ZHONG-BIN UNIVERSITY OF LOUISVILLE KY $184,680
Liver Cancer 2016 NCI 5R01CA120206-11 Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer MEHTA, ANAND DREXEL UNIVERSITY PA $329,172
Liver Cancer 2016 NCI 4F30CA176922-03 Recombinant Polymers for Transarterial Chemoembolization of Liver Cancer POURSAID, AZADEH UNIVERSITY OF UTAH UT $33,319
Liver Cancer 2016 NCI 5R21CA185274-02 Magnetic Micelles for Catheter-Directed Sorafenib Delivery to Liver Tumors KIM, DONG-HYUN NORTHWESTERN UNIVERSITY AT CHICAGO IL $201,623
Liver Cancer 2016 NCI 5R01CA175380-03 FoxM1 in liver cancer. RAYCHAUDHURI, PRADIP UNIVERSITY OF ILLINOIS AT CHICAGO IL $405,146
Liver Cancer 2016 NIDDK 5R01DK074932-10 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Liver Cancer 2016 NCI 5R01CA181658-02 MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors LARSON, ANDREW NORTHWESTERN UNIVERSITY AT CHICAGO IL $441,814
Liver Cancer 2016 NIAAA 5P50AA011999-18 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $203,571
Liver Cancer 2016 NIEHS 5R21ES023906-02 The antimicrobial triclosan is a potent liver tumor promoter YUEH, MEI-FEI UNIVERSITY OF CALIFORNIA SAN DIEGO CA $193,750
Liver Cancer 2016 NCI 5R01CA193244-06 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $368,367
Liver Cancer 2016 NCI 2P30CA014089-41 8293 Gastrointestinal Cancers Research Program (Project-006) KAHN, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $35,512
Liver Cancer 2016 NCI 4R01CA166111-04 Tumor antigen-specific T-cells and hepatocellular carcinoma KAPLAN, DAVID UNIVERSITY OF PENNSYLVANIA PA $332,000
Liver Cancer 2016 NCI 5R01CA121275-08 Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC) LEONE, GUSTAVO OHIO STATE UNIVERSITY OH $316,102
Liver Cancer 2016 NCI 5R01CA190844-02 Hepatic Stellate Cells and Liver Cancer SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $358,306
Liver Cancer 2016 NCI 5R01CA086978-13 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Liver Cancer 2016 NCI 5R01CA176012-03 Molecular and cellular communications in liver tumorigenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA SAN DIEGO CA $321,625
Liver Cancer 2016 NIAID 5R21AI118337-02 Host and viral determinants of hepatitis C virus macaque infection EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $263,629
Liver Cancer 2016 NIGMS 9R01GM118122-16 Metabolism of Carcinogens and Drugs by Human P450s GUENGERICH, F VANDERBILT UNIVERSITY TN $368,951
Liver Cancer 2016 NIDDK 5R01DK098424-03 Chemical probes targeting nuclear effector complex of the Hippo signaling pathway PAN, DUOJIA JOHNS HOPKINS UNIVERSITY MD $27,526
Liver Cancer 2016 NCI 5R01CA190776-02 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $636,299
Liver Cancer 2016 NCI 1R21CA190945-01A1 Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma KASEB, AHMED UNIVERSITY OF TX MD ANDERSON CAN CTR TX $174,000
Liver Cancer 2016 NCI 5R01CA168912-03 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI GEORGIA REGENTS UNIVERSITY GA $320,588
Liver Cancer 2016 NCI 4U01CA172320-04 Evaluation of HCC Response to Systemic Therapy with Quantitative MRI TAOULI, BACHIR ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $514,057
Liver Cancer 2016 NIA 5R01AG016927-18 The Role of Akt in Cell Survival and Cell Growth HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $451,912
Liver Cancer 2016 NCI 5R01CA185169-03 Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics MCKNIGHT, STEVEN UT SOUTHWESTERN MEDICAL CENTER TX $475,351
Liver Cancer 2016 NCI 4R01CA166213-05 Super-infection and virus spread during chronic hepadnaviral infection GUDIMA, SEVERIN UNIVERSITY OF KANSAS MEDICAL CENTER KS $319,945
Liver Cancer 2016 NCI 1R03CA201988-01 Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma TSAI, ROBERT TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $74,250
Liver Cancer 2016 NIGMS 4R01GM059419-14 Mitochondrial Calcium Signaling in Cell Death HAJNOCZKY, GYORGY THOMAS JEFFERSON UNIVERSITY PA $315,755
Liver Cancer 2016 NIAAA 4R01AA012863-16 Mechanisms of Liver Injury by Hepatitis C and Alcohol WEINMAN, STEVEN UNIVERSITY OF KANSAS MEDICAL CENTER KS $516,577
Liver Cancer 2016 NCI 4R01CA154986-04 The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel STILES, BANGYAN UNIVERSITY OF SOUTHERN CALIFORNIA CA $342,375
Liver Cancer 2016 NCI 1R01CA194307-01A1 2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization EISENBREY, JOHN THOMAS JEFFERSON UNIVERSITY PA $619,717
Liver Cancer 2016 NCI 2R01CA102325-10A1 15-PGDH in Cholangiocarcinogenesis WU, TONG TULANE UNIVERSITY OF LOUISIANA LA $344,269
Liver Cancer 2016 NCI 4R01CA118165-10 Role of Inflammation in tumor promotion and progression KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $446,701
Liver Cancer 2016 NCI 5R03CA195183-02 The role of Sirt2 in haptocarcinogenesis QIU, WEI LOYOLA UNIVERSITY CHICAGO IL $75,500
Liver Cancer 2016 NCI 1R01CA184456-01A1 VDAC Regulation of Warburg Metabolism in Hepatocarcinoma MALDONADO, EDUARDO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $341,981
Liver Cancer 2016 NCI 1R01CA202769-01 Development of cell-free DNA assays for HCC screening and liquid biopsy SU, YING-HSIU BARUCH S. BLUMBERG INSTITUTE PA $432,900
Liver Cancer 2016 NCI 4R01CA161694-05 Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse SELL, STEWART WADSWORTH CENTER NY $292,725
Liver Cancer 2016 NCI 5R01CA108614-10 Novel targets that are deregulated by loss of PTEN JOHNSON, DEBORAH BAYLOR COLLEGE OF MEDICINE TX $288,103
Liver Cancer 2016 NCI 5R01CA163287-05 Carbonyls to Cancer Therapeutics CHAIN, WILLIAM UNIVERSITY OF DELAWARE DE $283,653
Liver Cancer 2016 NCI 5R01CA188506-02 Dissection of Pten-regulated signals in hepatopathogenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA SAN DIEGO CA $354,563
Liver Cancer 2016 NIDDK 5R01DK104956-02 Molecular Imaging of Liver Fibrosis FUCHS, BRYAN MASSACHUSETTS GENERAL HOSPITAL MA $532,832
Liver Cancer 2016 NCI 1R21CA202852-01 DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER HELD, JASON WASHINGTON UNIVERSITY MO $152,500
Liver Cancer 2016 NCI 4R01CA083650-14 Altered Growth Factor Pathways in Biliary Cancer SIRICA, ALPHONSE VIRGINIA COMMONWEALTH UNIVERSITY VA $307,269
Liver Cancer 2016 NCI 4R01CA164029-05 Murine Model of HCV-Associated Human Liver Cancer LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $470,695
Liver Cancer 2016 NCI 5R21CA185943-02 Beneficial effects of Honokiol against liver cancer SAXENA, NEERAJ UNIVERSITY OF MARYLAND BALTIMORE MD $179,403
Liver Cancer 2016 NCI 4R01CA080946-16 Selenoproteins as targets for cancer prevention GLADYSHEV, VADIM BRIGHAM AND WOMEN'S HOSPITAL MA $316,004
Liver Cancer 2016 NCI 5R44CA196025-02 Multifunctional Hollow Gold Nanospheres for Concurrent Photothermal-Chemotherapy WANG, Y OCEAN NANOTECH, LLC CA $500,000
Liver Cancer 2016 NCI 5R01CA195787-02 A scalable platform for target validation in GEMM models of gastrointestinal malignancies. LOWE, SCOTT SLOAN-KETTERING INST CAN RESEARCH NY $648,617
Liver Cancer 2016 NCI 7R01CA127387-09 Role of the RB tumor suppressor in liver tumorigenesis KNUDSEN, ERIK UNIVERSITY OF ARIZONA AZ $400,509
Liver Cancer 2016 NICHD 4R01HD024455-27 Novel Approaches to Understanding the Nutrient Regulation of Fetal Somatic Growth GRUPPUSO, PHILIP RHODE ISLAND HOSPITAL RI $399,201
Liver Cancer 2016 NCI 4R01CA165076-05 Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma ROBERTS, LEWIS MAYO CLINIC ROCHESTER MN $327,228
Liver Cancer 2016 NIDA 4R01DA034637-04 Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics HAGAN, HOLLY NEW YORK UNIVERSITY NY $654,934
Liver Cancer 2016 NIDDK 5R01DK054921-18 Cyclin D1/CDK4 Complex in Hepatocyte Proliferation ALBRECHT, JEFFREY UNIVERSITY OF MINNESOTA MN $388,571
Liver Cancer 2016 NCI 5R44CA165314-03 A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC) LU, XUANYONG IMCARE BIOTECH PA $657,468
Liver Cancer 2016 NCI 5R21CA188472-02 Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma RAY, RATNA SAINT LOUIS UNIVERSITY MO $177,066
Liver Cancer 2016 NCI 5R01CA188305-02 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $339,023
Liver Cancer 2016 NIDDK 4R01DK059427-16 Mechanisms of Carcinogenesis in Biliary Epithelia GORES, GREGORY MAYO CLINIC ROCHESTER MN $381,978
Liver Cancer 2016 NIEHS 4P42ES010337-15 8807 Project 4: Antioxidant Protection by Bilirubin in Arsenic Induced Toxicity TUKEY, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $289,934
Liver Cancer 2016 NIEHS 4P42ES010337-15 5775 Project 1: Effects of Superfund Toxicants on Liver Cancer Progenitors KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $290,389
Liver Cancer 2016 NCI 5R01CA190144-02 Liver Cancer Risk with rAAV Gene Therapy GROMPE, MARKUS OREGON HEALTH & SCIENCE UNIVERSITY OR $636,568
Liver Cancer 2016 NCI 5K08CA194268-02 Novel targeted therapies for isocitrate dehydrogenase mutant cholangiocarcinoma SAHA, SUPRIYA MASSACHUSETTS GENERAL HOSPITAL MA $179,280
Liver Cancer 2016 NCATS 1R41TR001312-01A1 Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists OUPICKY, DAVID BOHEMICA PHARMACEUTICALS, LLC NE $347,546
Liver Cancer 2016 NCI 1R41CA195908-01A1 Small molecule inhibitors targeting oncogenic drivers of hepatocellular carcinoma WAJAPEYEE, NARENDRA L2 DIAGNOSTICS, LLC CT $298,959
Liver Cancer 2016 NIDDK 5R01DK102667-02 Innovative Genetic Approaches for Hepatic Repopulation KAESTNER, KLAUS UNIVERSITY OF PENNSYLVANIA PA $360,000
Liver Cancer 2016 NCI 5R01CA186566-02 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $657,227
Liver Cancer 2016 NCI 1R01CA197081-01A1 Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation AHMED, MUNEEB BETH ISRAEL DEACONESS MEDICAL CENTER MA $440,786
Liver Cancer 2016 NIDDK 1F31DK107254-01A1 SRC-2 and AMPKa2 in liver metabolism and Non-Alcoholic Fatty Liver Disease FLEET, TIFFANY BAYLOR COLLEGE OF MEDICINE TX $43,576
Liver Cancer 2016 NCI 5R01CA174735-03 The role of MDM2-MTBP axis in cancer metastasis IWAKUMA, TOMOO UNIVERSITY OF KANSAS MEDICAL CENTER KS $313,325
Liver Cancer 2016 NCI 1R01CA200597-01A1 HMGB1 as Link Between Hepatocellular Injury and HCC SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $458,761
Liver Cancer 2016 NCI 4P01CA080124-15 6417 Overcoming Evasion from Sorafenib in HCC DUDA, DAN MASSACHUSETTS GENERAL HOSPITAL MA $254,705
Liver Cancer 2016 NCI 4P01CA080124-15 6421 Surgical and Animal Core FUKUMURA, DAI MASSACHUSETTS GENERAL HOSPITAL MA $436,627
Liver Cancer 2016 NCI 4R01CA089121-10 Hepatitis C Virus and Hepatocellular Carcinoma DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $237,038
Liver Cancer 2016 NCI 5R01CA194574-02 Enhancing Liver Cancer Treatment With Image-Guided Magnetic Hyperthermia LIAPI, ELENI JOHNS HOPKINS UNIVERSITY MD $659,622
Liver Cancer 2016 NCI 4R01CA112192-09 Real-time Ultrasonic Monitoring of Tumor Ablation VARGHESE, TOMY UNIVERSITY OF WISCONSIN-MADISON WI $249,074
Liver Cancer 2016 NCI 5R01CA169919-05 Metabolic control of hepatocellular carcinoma by PGC1alpha GIRNUN, GEOFFREY STATE UNIVERSITY NEW YORK STONY BROOK NY $359,587
Liver Cancer 2016 NCI 5R01CA190525-02 Reactivation of embryonic growth programs in liver cancer ZHU, HAO UT SOUTHWESTERN MEDICAL CENTER TX $370,194
Liver Cancer 2016 NCI 4R01CA161209-06 Functional Genomics and Molecular Imaging of Liver Disease and Cancer KWEE, SANDI QUEEN'S MEDICAL CENTER HI $325,386
Liver Cancer 2016 NIBIB 4R01EB016960-04 Pressure-Driven Local Drug Delivery System for Treatment of Liver Cancer EXNER, AGATA CASE WESTERN RESERVE UNIVERSITY OH $356,625
Liver Cancer 2016 NCI 4R01CA114102-10 The RB pathway in liver cancer SAGE, JULIEN STANFORD UNIVERSITY CA $278,578
Liver Cancer 2016 NCI 5R01CA164335-06 An Orthotopic Murine Model of HCC: Immunotolerance and Prevention STAVELEY-O'CARROLL, KEVIN UNIVERSITY OF MISSOURI-COLUMBIA MO $301,525
Liver Cancer 2016 NCI 5R01CA190678-02 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $364,322
Liver Cancer 2016 NCI 5P01CA059827-18 5908 Response-driven Treatment of Hepatocellular Carcinoma LAWRENCE, THEODORE UNIVERSITY OF MICHIGAN MI $342,669
Liver Cancer 2016 NCI 4R01CA172713-04 PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL MCCARTY, DOUGLAS RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $303,988
Liver Cancer 2016 NIBIB 5R01EB018849-03 Ultrasound-Guided Robotic Needle Steering for Ablation of Liver Cancer OKAMURA, ALLISON STANFORD UNIVERSITY CA $361,256
Liver Cancer 2016 NCI 5F32CA192633-02 Disruption of the Host DNA Damage Response by Hepatitis C Virus MITCHELL, JONATHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $32,484
Liver Cancer 2016 NCI 5R21CA191814-02 Autophagy, mTOR inhibitors and phenformin in hepatocellular carcinoma MERCER, CAROL UNIVERSITY OF CINCINNATI OH $184,663
Liver Cancer 2016 NCI 5R01CA194533-02 Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity HETTS, STEVEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $522,926
Liver Cancer 2016 NCI 5R01CA181566-02 Compact Representations of Dynamic Liver MRI SPINCEMAILLE, PASCAL WEILL MEDICAL COLL OF CORNELL UNIV NY $387,731
Liver Cancer 2016 NCI 5R21CA198490-02 Glutamine catabolism in c-Myc driven liver tumor development CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $206,843
Liver Cancer 2016 NCI 1P01CA203628-01 7232 Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression BRITTEN, CAROLYN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $541,564
Liver Cancer 2016 NIDDK 1R01DK108743-01 Control of stellate cells-driven liver cancer by the p62/NBR1 adapters MOSCAT, JORGE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $454,727
Liver Cancer 2016 NCI 1R01CA204586-01 Yap and beta-catenin interactions in liver: Implications in Pathophysiology MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $425,315
Liver Cancer 2016 NCI 1R01CA203985-01 Mechanism of Met-Induced Hepatocyte Survival ZARNEGAR, REZA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $352,275
Liver Cancer 2016 NCI 5R01CA051497-25 MYC--Transcription and Apoptosis DANG, CHI UNIVERSITY OF PENNSYLVANIA PA $733,273
Liver Cancer 2016 NCI 1R01CA204373-01 Imaging Liver Cancer Proliferation LEE, ZHENGHONG CASE WESTERN RESERVE UNIVERSITY OH $321,679
Liver Cancer 2016 NIDDK 4R01DK100287-04 Targeting beta-catenin in liver pathology: Novel Interactions, Novel Paradigms MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $328,340
Liver Cancer 2016 NCI 4P30CA046592-28 6463 Gastrointestinal Oncology WICHA, MAX UNIVERSITY OF MICHIGAN MI $194,891
Liver Cancer 2016 NIAAA 5U01AA022614-03 The Role of IL-17 in Alcoholic Liver Disease and Cancer KISSELEVA, TATIANA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $353,250
Liver Cancer 2016 NIBIB 1R21EB022298-01 3D Passive Cavitation Imaging-Guided Therapeutic Delivery of MicroRNA into Cancer WILLMANN, JUERGEN STANFORD UNIVERSITY CA $195,444
Liver Cancer 2016 NIAID 5R21AI113394-02 Hepatitis B virus transcriptional interference and liver cancer-related mutations TONG, SHUPING RHODE ISLAND HOSPITAL RI $241,500
Liver Cancer 2016 NIBIB 1R21EB022291-01 Transarterial Immunomodulatory Embolization: A novel approach to cancer therapy AMEER, GUILLERMO NORTHWESTERN UNIVERSITY IL $238,870
Liver Cancer 2016 NCI 5R01CA183764-02 The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle GRADILONE, SERGIO UNIVERSITY OF MINNESOTA MN $348,844
Liver Cancer 2016 NCI 5R01CA163805-06 Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans JUON, HEE-SOON THOMAS JEFFERSON UNIVERSITY PA $330,974
Liver Cancer 2016 NCI 5R01CA172086-03 PROHIBITIN 1 IN LIVER INJURY AND CANCER LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $312,404
Liver Cancer 2016 NIBIB 1R01EB022148-01 Cancer-specific nanoparticle-mediated gene therapy to treat hepatocellular carcinoma GREEN, JORDAN JOHNS HOPKINS UNIVERSITY MD $364,500
Liver Cancer 2016 NCCIH 5R01AT001576-14 Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver Disease LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $297,230
Liver Cancer 2016 NCI 5R01CA182264-03 Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer PAN, XIAOCHUAN UNIVERSITY OF CHICAGO IL $443,731
Liver Cancer 2016 NCI 5R01CA196967-02 MRI-Guided Irreversible Electroporation Ablation for Liver Tumors ZHANG, ZHUOLI NORTHWESTERN UNIVERSITY AT CHICAGO IL $347,209
Liver Cancer 2016 NIDDK 5R01DK107288-02 S-Adenosylmethionine in Protein Posttranslational Modifications and HCC Treatment LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $393,750
Liver Cancer 2016 NIAAA 5R01AA023146-11 Role of Beta Spectrin and Smad in Alcohol Induced Liver and GI Cell Proliferation MISHRA, LOPA GEORGE WASHINGTON UNIVERSITY DC $285,300
Liver Cancer 2016 NCI 5P30CA142543-07 6364 Population Science and Cancer Control Scientific Program WILLSON, JAMES UT SOUTHWESTERN MEDICAL CENTER TX $53,100
Liver Cancer 2016 NCI 5K08CA172288-05 Mechanisms and modifiers of beta-catenin-induced hepatic tumorigenesis EVASON, KIMBERLEY UNIVERSITY OF UTAH UT $150,763
Liver Cancer 2016 NIDDK 4R01DK097249-04 Med1 in Liver Metabolism, Regeneration and Cancer THIMMAPAYA, BAYAR NORTHWESTERN UNIVERSITY AT CHICAGO IL $336,038
Liver Cancer 2016 NCI 1R21CA205501-01 Developing Therapy for the Treatment of Cholangiocarcinoma YOON, KARINA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $191,835
Liver Cancer 2016 NCI 1R01CA190606-01A1 Signaling cascades in cholangiocarcinoma development CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $362,569
Liver Cancer 2016 NCI 4R01CA180083-04 (PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip QIN, LIDONG METHODIST HOSPITAL RESEARCH INSTITUTE TX $505,194
Liver Cancer 2016 NCI 5R01CA203565-02 Nutritional Control of Cancer Cell Function by Amino Acids KILBERG, MICHAEL UNIVERSITY OF FLORIDA FL $343,125
Liver Cancer 2016 NCI 5R01CA197128-02 Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis QIU, WEI LOYOLA UNIVERSITY CHICAGO IL $351,229
Liver Cancer 2016 NCI 5R03CA184531-02 Murine Models on SALL4 in Hepatocellular Carcinoma CHAI, LI BRIGHAM AND WOMEN'S HOSPITAL MA $81,775
Liver Cancer 2016 NIDDK 2R01DK090311-06 Estrogen Regulation of Hepatic Growth GOESSLING, WOLFRAM BRIGHAM AND WOMEN'S HOSPITAL MA $637,107
Liver Cancer 2016 NCI 4R01CA164719-05 Role of liver fluke granulin in cholangiocarcinogenesis BRINDLEY, PAUL GEORGE WASHINGTON UNIVERSITY DC $328,400
Liver Cancer 2016 NCI 1R01CA195524-01A1 Early Detection of Hepatocellular Carcinoma BERETTA, LAURA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $645,417
Liver Cancer 2016 NCI 3R01CA062130-20S1A1 Role of Heat Shock transcription factor HSF1 in tumorigenesis MIVECHI, NAHID GEORGIA REGENTS UNIVERSITY GA $142,120
Liver Cancer 2016 NCI 5R01CA200007-02 Multiplexed imaging of biliary intra-epithelial neoplasia SEIBEL, ERIC UNIVERSITY OF WASHINGTON WA $589,117
Liver Cancer 2016 NIDDK 5R01DK100490-04 GENETICALLY MODIFIED HEPATOCYTES TO ACHIEVE SUCCESS IN LIVER CELL TRANSPLANTATION SHAFRITZ, DAVID ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $667,576
Liver Cancer 2016 NIEHS 5R01ES025909-02 Molecular Basis of Cancer Cell Metabolic Reprogramming WANG, LI UNIVERSITY OF CONNECTICUT STORRS CT $355,500
Liver Cancer 2016 NIAID 5P50AI098639-05 6987 Pathogenesis of Opisthorchiasis induced persistent periductal fibrosis and CCA SRIPA, BANCHOB KHON KAEN UNIVERSITY THAIL $168,141
Liver Cancer 2016 NIAID 5P50AI098639-05 6988 Opisthorchis Viverrini ES Proteins and the Tumorgenic Environment LAHA, THEWARACH KHON KAEN UNIVERSITY THAIL $112,596
Liver Cancer 2016 NCI 5K08CA193915-02 The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome KALISH, JENNIFER CHILDREN'S HOSP OF PHILADELPHIA PA $140,504
Liver Cancer 2016 NCI 5R01CA196692-02 Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality? IOANNOU, GEORGE SEATTLE INST FOR BIOMEDICAL/CLINICAL RES WA $209,012
Liver Cancer 2016 NCI 1R01CA200310-01A1 Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma MACLEOD, KAY UNIVERSITY OF CHICAGO IL $397,573
Liver Cancer 2016 NCI 1R01CA198103-01A1 ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $765,053
Liver Cancer 2016 NIDDK 4R01DK093646-05 Identifying and modulating therapeutic targets in a model of hepatitis B BARON, JODY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $344,738
Liver Cancer 2016 NCI 5R01CA062130-21 Role of heat shock transcription factor HSF1 in tumoroginesis MIVECHI, NAHID GEORGIA REGENTS UNIVERSITY GA $556,510
Liver Cancer 2016 NCI 5U01CA185188-02 Analysis of Racial Disparities in HCC by Systems Metabolomics RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $255,915
Liver Cancer 2016 NCI 5U01CA188387-02 Gut microbiota mediated bile acid alterations in hepatic carcinogenesis JIA, WEI UNIVERSITY OF HAWAII AT MANOA HI $571,982
Liver Cancer 2016 NIDDK 4K01DK099405-04 Identifying a role for commensal bacteria on the liver immune priming environment PUBLICOVER, JEAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $143,014
Liver Cancer 2016 NIDDK 4K01DK097291-04 Deleted in liver cancer 1 (DLC1) in liver development and disease SHIH, YI-PING UNIVERSITY OF CALIFORNIA AT DAVIS CA $117,873
Liver Cancer 2016 NCI 5U01CA179582-03 The Role of Probiotic Bifidobacteria and Bile Acid Metabolism in Carcinogenesis WAN, YU-JUI UNIVERSITY OF CALIFORNIA AT DAVIS CA $530,656
Liver Cancer 2016 NCI 5R01CA135069-07 Glycans in Hepatocellular Carcinoma GOLDMAN, RADOSLAV GEORGETOWN UNIVERSITY DC $403,705
Liver Cancer 2016 NCI 5R01CA136606-08 Molecular Genetics of Liver Cancers CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $356,625
Liver Cancer 2016 RMAP 4U19CA179512-04 7166 Function of Extracellular Small RNAs in Conditional Mouse Models of Liver Cancer BLELLOCH, ROBERT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $135,553
Liver Cancer 2016 NCI 5R01CA172230-03 TREM-1 and Its Implications to Cancer HORUZSKO, ANATOLIJ GEORGIA REGENTS UNIVERSITY GA $315,400
Liver Cancer 2016 NCI 4U01CA168856-05 Aberrantly secreted glycoproteins as markers of liver cancer MEHTA, ANAND DREXEL UNIVERSITY PA $289,144
Liver Cancer 2016 NCI 5K99CA191152-02 Development of mosaic mouse models of HCC for genetic interspecies inference FONT-BURGADA, JOAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $109,620
Liver Cancer 2016 NCI 4R01CA177686-04 Regulation of molecular thermal ablative resistance in hepatocellular carcinoma WOODRUM, DAVID MAYO CLINIC ROCHESTER MN $329,925
Liver Cancer 2016 NCI 5K22CA184146-03 Metabolic reprogramming in liver cancer cells by a novel tumor suppressor ZHANG, YUXIA UNIVERSITY OF KANSAS MEDICAL CENTER KS $118,152
Liver Cancer 2016 RMAP 5UH3TR000884-04 Extracellular non-coding RNA biomarkers of hepatocellular cancer PATEL, TUSHAR MAYO CLINIC JACKSONVILLE FL $986,936
Liver Cancer 2016 NCI 1R01CA206465-01 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer JUSTICE, AMY YALE UNIVERSITY CT $563,374
Liver Cancer 2016 NCI 5K07CA197179-02 Genetic and Environmental Risk of Liver Disease/Cancer among Mexicans FLORES, YVONNE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $160,920
Liver Cancer 2016 NCI 5F31CA200373-02 Injectable Implants for Increased Tumor Treatment Volume Using Pressure Driven Diffusion HERNANDEZ, CHRISTOPHER CASE WESTERN RESERVE UNIVERSITY OH $32,765
Liver Cancer 2016 NIDDK 5K01DK106346-02 Altered endosomal protein sorting in the pathogenesis of hepatocellular carcinoma SINGLA, AMIKA UT SOUTHWESTERN MEDICAL CENTER TX $124,040
Liver Cancer 2016 FIC 5U54CA190165-03 7860 Adminstrative and Coordinating Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $8,131
Liver Cancer 2016 NCI 5U54CA190165-03 7860 Adminstrative and Coordinating Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $113,817
Liver Cancer 2016 FIC 5U54CA190165-03 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $11,952
Liver Cancer 2016 NCI 5U54CA190165-03 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $167,311
Liver Cancer 2016 FIC 5U54CA190165-03 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $14,853
Liver Cancer 2016 NCI 5U54CA190165-03 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $207,911
Liver Cancer 2016 FIC 5U54CA190165-03 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $8,991
Liver Cancer 2016 NCI 5U54CA190165-03 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $125,855
Liver Cancer 2016 FIC 5U54CA190165-03 7874 Developmental Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $6,073
Liver Cancer 2016 NCI 5U54CA190165-03 7874 Developmental Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $85,006
Liver Cancer 2016 NIDDK 4R01DK099558-04 Molecular Prognostic Indicators in Liver Cirrhosis and Cancer HOSHIDA, YUJIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $683,136
Liver Cancer 2016 NCI 1R43CA206683-01 A Novel Oral Therapeutic for Hepatocellular Carcinoma (HCC) GROSS, COLEMAN EIGER GROUP INTERNATIONAL, INC. CA $267,105
Liver Cancer 2016 NCI 2R44CA186410-02A1 Optimization of a clinical stage nanoparticle drug delivery platform BROWN, BOB DICERNA PHARMACEUTICALS, INC. MA $1,000,000
Liver Cancer 2016 NCI 4U01CA168926-05 Alliance of Glycobiologists for Detection of Cancer GOLDMAN, RADOSLAV GEORGETOWN UNIVERSITY DC $505,313
Liver Cancer 2016 NCI 4R01CA172302-04 Genetics pathways in intra-hepatic cholangiocarcinoma HEZEL, ARAM UNIVERSITY OF ROCHESTER NY $318,513
Liver Cancer 2016 NCI 5R44CA162783-03 CC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv COPE, FREDERICK NAVIDEA BIOPHARMACEUTICALS, INC. OH $688,135
Liver Cancer 2016 NCI 5R44CA195793-02 Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors PARETTE, MYLISA KEYSTONE NANO, INC. PA $942,527
Liver Cancer 2016 NCI 5P30CA196521-02 7061 Liver Cancer (LC) (Project-003) FRIEDMAN, SCOTT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $10,690
Liver Cancer 2016 NCI 5DP5OD021391-02 Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology GADE, TERENCE UNIVERSITY OF PENNSYLVANIA PA $399,999
Liver Cancer 2016 NIDCR 5DP5OD021391-02 Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology GADE, TERENCE UNIVERSITY OF PENNSYLVANIA PA $1
Liver Cancer 2016 NCI 5U54CA193417-02 7363 Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology: Administrative Core DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $386,364
Liver Cancer 2016 NCI 5U54CA193417-02 7364 Core 1: Cell and Tissue Core WELLS, REBECCA UNIVERSITY OF PENNSYLVANIA PA $267,114
Liver Cancer 2016 NCI 5U54CA193417-02 7365 Core 2: Theory Core - Multiscale models for mechano-chemical phenomena LIU, ANDREA UNIVERSITY OF PENNSYLVANIA PA $280,471
Liver Cancer 2016 NCI 5U54CA193417-02 7366 Project 1: Mechanisms of Stiffening in Liver Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $352,015
Liver Cancer 2016 NCI 5U54CA193417-02 7367 Project 2: Physical Mechanisms and Clinical Implications of Mechano-transduction RADHAKRISHNAN, RAVI UNIVERSITY OF PENNSYLVANIA PA $326,372
Liver Cancer 2016 NCI 5U54CA193417-02 7368 Project 3: Nuclear Rheology & Stability in Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $339,195
Liver Cancer 2016 NCI 5U54CA193417-02 7369 PSOC@Penn Education and Outreach DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $143,098
Liver Cancer 2016 NCI 1R56CA207929-01 Cellular Pathogenesis of Fibrolamellar Hepatocellular Carcinoma SIMON, SANFORD ROCKEFELLER UNIVERSITY NY $296,625
Liver Cancer 2016 NCI 2R01CA160254-05 Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach LUBMAN, DAVID UNIVERSITY OF MICHIGAN MI $374,611
Liver Cancer 2016 NIDDK 1R01DK107451-01A1 The role of AEG-1 in NASH and NASH-HCC SARKAR, DEVANAND VIRGINIA COMMONWEALTH UNIVERSITY VA $363,258
Liver Cancer 2016 NCI 1R01CA201127-01A1 Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology CRESSMAN, ERIK UNIVERSITY OF TX MD ANDERSON CAN CTR TX $372,942
Liver Cancer 2016 NIDDK 1R01DK106395-01A1 Metabolic imaging of nonalcoholic fatty liver disease MAYER, DIRK UNIVERSITY OF MARYLAND BALTIMORE MD $579,504
Liver Cancer 2016 NCI 1R21CA201867-01A1 Neurotensin in Fibrolamellar Liver Cancer RIEHLE, KIMBERLY UNIVERSITY OF WASHINGTON WA $168,019
Liver Cancer 2016 NCI 2R01CA080024-19 Intra and Extra-Chromosomal Probes for Mutagenesis by Carcinogens ESSIGMANN, JOHN MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $342,076
Liver Cancer 2016 NIDDK 1R01DK105198-01A1 Metabolic Regulation of Liver Growth GOESSLING, WOLFRAM BRIGHAM AND WOMEN'S HOSPITAL MA $547,130
Liver Cancer 2016 NIDDK 1R01DK103735-01A1 Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B COOPER, STEWART CALIFORNIA PACIFIC MED CTR RES INSTITUTE CA $795,453
Liver Cancer 2016 NCI 1R21CA202396-01A1 The role of IL-27 cytokine in hepatocellular carcinoma (HCC) development KOLTSOVA, EKATERINA RESEARCH INST OF FOX CHASE CAN CTR PA $232,943
Liver Cancer 2016 NIDDK 7R01DK100289-03 Signaling Pathways Influencing Liver Disease Phenotype in Antitrypsin Deficiency PERLMUTTER, DAVID WASHINGTON UNIVERSITY MO $460,770
Liver Cancer 2016 NCI 1R01CA206180-01A1 Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment GESCHWIND, JEAN-FRANCOIS YALE UNIVERSITY CT $669,786
Liver Cancer 2016 NIAID 1F32AI126660-01 RNA-Protein Interactions During Hepatitis C Virus Infection ADAMS, REBECCA YALE UNIVERSITY CT $54,294
Liver Cancer 2016 NCI 4R00CA190783-02 Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN TX $248,966
Liver Cancer 2016 NIDDK 1F32DK109651-01A1 Mechanisms of differential susceptibility to nonalcoholic fatty liver disease RIORDAN, JESSE PACIFIC NORTHWEST RESEARCH INSTITUTE WA $56,118
Liver Cancer 2016 NIAAA 1F32AA025271-01 The role of mechanical signaling in alcoholic liver disease and hepatocellular carcinoma WRIGHTON, PAUL BRIGHAM AND WOMEN'S HOSPITAL MA $54,294
Liver Cancer 2016 NCI 1F31CA210639-01 Improving Sorafenib; a multi-targeted kinase inhibitor used for the treatment of hepatocellular carcinoma by mechanistically dissecting out its underlying targets and anti-targets YU, JIA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $40,776
Liver Cancer 2016 NCI 1R01CA204145-01A1 Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $440,818
Liver Cancer 2016 NCI 1R01CA206167-01A1 Hexokinase 2 in liver cancer HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $398,154
Liver Cancer 2016 NCI 3R01CA193244-06S1 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $61,549
Liver Cancer 2016 NCI 7R01CA164335-05 An Orthotopic Murine Model of HCC: Immunotolerance and Prevention STAVELEY-O'CARROLL, KEVIN UNIVERSITY OF MISSOURI-COLUMBIA MO $197,336
Liver Cancer 2016 NCI 1R44CA203276-01A1 Development and testing of MRI-mediated radiofrequency ablation system and probes NEVO, EREZ ROBIN MEDICAL, INC. MD $749,066
Liver Cancer 2016 NCI 2R42CA168123-02A1 In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma GHANDEHARI, HAMID THERATARGET UT $400,462
Liver Cancer 2016 RMAP 1R03CA211210-01 A Multi-Omics Approach to Identify a Biomarker Panel for the Early Detection of Hepatocellular Carcinoma in Hepatitis C+ Individuals SPRATT, HEIDI UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $155,000
Liver Cancer 2016 NIBIB 1R01EB022075-01A1 Imaging and Dosimetry of Yttrium-90 for Personalized Cancer Treatment DEWARAJA, YUNI UNIVERSITY OF MICHIGAN MI $461,991
Liver Cancer 2016 NCI 3R43CA192850-01S1 Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions STICE, JIM TWIN STAR TDS, LLC KY $40,000
Liver Cancer 2016 NCI 1R43CA213610-01 Urine DNA Kit for monitoring HCC recurrence JAIN, SURBHI JBS SCIENCE, INC. PA $300,000
Liver Cancer 2016 RMAP 4UH3TR000914-04 Targeted delivery of microRNA-loaded microvesicle for cancer therapy SCHMITTGEN, THOMAS UNIVERSITY OF FLORIDA FL $800,677
Liver Cancer 2016 NIDDK 1F32DK111151-01A1 A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation WALESKY, CHAD BRIGHAM AND WOMEN'S HOSPITAL MA $56,118
Liver Cancer 2016 NCI 3U01CA185188-02S1 Analysis of Racial Disparities in HCC by Systems Metabolomics RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $193,780
Liver Cancer 2016 NCI 3R21CA188472-02S1 Establishment of PDX mouse models and cell lines from hepatitis C virus associated liver cancer patients from CA and AA ethnic groups RAY, RATNA SAINT LOUIS UNIVERSITY MO $199,954
Liver Cancer 2016 RMAP 3UH3TR000884-04S1 Extracellular non-coding RNA biomarkers of hepatocellular cancer PATEL, TUSHAR MAYO CLINIC JACKSONVILLE FL $10,955
Liver Cancer 2016 RMAP 3UH3TR000914-04S1 Targeted delivery of microRNA-loaded microvesicle for cancer therapy SCHMITTGEN, THOMAS UNIVERSITY OF FLORIDA FL $62,500
Liver Cancer 2016 NIDDK 3R01DK107288-02S1 S-Adenosylmethionine in Protein Posttranslational Modifications and HCC Treatment LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $27,564
Liver Cancer 2016 NIDDK 7R01DK098424-04 Chemical probes targeting nuclear effector complex of the Hippo signaling pathway PAN, DUOJIA UT SOUTHWESTERN MEDICAL CENTER TX $324,824
Liver Cancer 2016 NCI 3DP2CA195764-01S1 Oncolytic Virotherapy in Hepatocellular Cancer BORAD, MITESH MAYO CLINIC ARIZONA AZ $219,502
Liver Cancer 2016 NCI 1ZIACP005782-22 Epidemiology of Oncogenic Viruses O'BRIEN, THOMAS NIH $251,756
Liver Cancer 2016 NCI 1ZIACP010127-21 Etiologic Studies of Diet and Cancer FREEDMAN, NEAL NIH $61,954
Liver Cancer 2016 NCI 1ZIACP010128-21 Therapeutic and Diagnostic Factors as Related to Cancer Risk TRABERT, BRITTON NIH $206,904
Liver Cancer 2016 NCI 1ZIACP010158-16 Studies of Rare Cancers MCGLYNN, KATHERINE NIH $582,056
Liver Cancer 2016 NCI 1ZIACP010184-14 Consultation and Collaboration GRAUBARD, BARRY NIH $1,770,645
Liver Cancer 2016 NCI 1ZIABC005793-22 Mechanism of viral hepatitis-mediated hepatocarcinogenesis WANG, XIN NIH $111,437
Liver Cancer 2016 NCI 1ZIABC010297-19 Identification of Genetic Factors Associated with Infectious Diseases WINKLER, CHERYL NIH $462,474
Liver Cancer 2016 NCI 1ZIABC010313-18 Molecular signatures for liver cancer diagnosis and treatment stratification WANG, XIN NIH $891,493
Liver Cancer 2016 NCI 1ZIABC010793-10 Role of inflammation, innate resistance, and immunity in carcinogenesis TRINCHIERI, GIORGIO NIH $1,078,868
Liver Cancer 2016 NCI 1ZIABC010876-09 The role of cancer stem cells in liver cancer heterogeneity and subtypes WANG, XIN NIH $891,493
Liver Cancer 2016 NCI 1ZIABC010877-09 The identification of human hepatocellular carcinoma metastasis genes WANG, XIN NIH $334,310
Liver Cancer 2016 NCI 1ZIABC010891-09 Development of new antibody-based cancer therapies HO, MITCHELL NIH $1,192,823
Liver Cancer 2016 NCI 1ZIABC011343-07 Clinical protocols for the treatment of gastrointestinal cancer GRETEN, TIM NIH $199,565
Liver Cancer 2016 NCI 1ZIDBC011540-03 Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core HASSAN, RAFFIT NIH $2,214,926
Liver Cancer 2016 NICHD 1ZIAHD008804-10 The Role of Carboxypeptidase E in Cancer LOH, YOKE NIH $609,044
Liver Cancer 2016 NIEHS 1ZIAES103166-04 DNA Microarray Data Analysis SHOCKLEY, KEITH NIH $97,458
Liver Cancer 2016 NIAID 1ZIAAI000999-10 Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases FARCI, PATRIZIA NIH $1,253,600
Liver Cancer 2016 NCI 261201600058C-0-0-1 IGF::OT::IGF CELL-FREE CIRCULATING DBA-BASED ASSAY DEVELOPMENT FOR LIVER CANCER SCREENING JAIN, SURBHI JBS SCIENCE, INC. PA $273,600
Liver Cancer 2016 NCATS 1ZIATR000118-02 NPC/MIPE Toxicity Screen of IDH1 Inhibitors against Cholangiocarcinoma Cell Lines HALL, MATTHEW NIH $37,474


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer